Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

BLOCK LISTING RETURN

1 Jul 2024 11:24

RNS Number : 6149U
Oxford Biomedica PLC
01 July 2024
 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

306,521

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

11,802

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

294,719

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

250,368

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

250,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

107,069

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

393,299

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

268,072

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

50,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

31,281

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

286,791

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

339,753

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

339,753

 

Name of contact:

Natalie Walter, Company Secretary

Telephone number of contact:

01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRRBMMTMTTMBJI
Date   Source Headline
15th Jun 201511:20 amRNSDirector/PDMR Shareholding
11th Jun 20151:01 pmRNSDirectors' Interest in Share Options
10th Jun 201512:09 pmRNSDirector/PDMR Shareholding
9th Jun 20153:13 pmRNSOxford BioMedica plc Director's Share Purchase
9th Jun 20152:56 pmRNSDirector/PDMR Shareholding
1st Jun 20157:00 amRNSTotal Voting Rights
22nd May 20157:00 amRNSDirector/PDMR Shareholding
20th May 20157:00 amRNSDirector/PDMR Shareholding
8th May 20157:00 amRNSDeferred Bonus Plan
7th May 20151:02 pmRNSResult of AGM
7th May 201512:37 pmRNSAppointment of Non-Executive Director
7th May 20157:00 amRNSInterim Management Statement
5th May 20157:02 amRNSPresentation of RetinoStat® results
5th May 20157:02 amRNSSummary of ProSavin® data
1st May 20157:00 amRNSTotal Voting Rights
2nd Apr 20153:40 pmRNS2014 Annual Report and Accounts & AGM Notification
1st Apr 20154:43 pmRNSHolding(s) in Company
1st Apr 201512:27 pmRNSOxford BioMedica Total Voting Rights
20th Mar 20157:00 amRNSOXB Present at 3rd Annual Regen Med Investor Day
16th Mar 20158:59 amRNSOxford BioMedica plc Director's Share Purchase
13th Mar 20157:00 amRNSPreliminary Results
6th Mar 20157:00 amRNSNotice of Preliminary Results
5th Mar 20159:02 amRNSAnnounces Presentation at Annual ROTH Conference
3rd Mar 20157:00 amRNSCredit Suisse's Global Healthcare Conference
3rd Mar 20157:00 amRNSTotal Voting Rights
23rd Feb 20153:36 pmRNSChief Secretary to the Treasury visits OXB
16th Feb 201511:41 amRNSChange of Registered Address
30th Jan 201510:47 amRNSTotal Voting Rights
28th Jan 20154:40 pmRNSSecond Price Monitoring Extn
28th Jan 20154:35 pmRNSPrice Monitoring Extension
31st Dec 20147:00 amRNSBLOCK LISTING RETURN
31st Dec 20147:00 amRNSTotal Voting Rights
18th Dec 20142:45 pmRNSDirector's Share Purchase.
18th Dec 20147:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES.
16th Dec 20143:50 pmRNSDirector PDMR Shareholding
16th Dec 20143:50 pmRNSNotification Of Major Interest In Shares
1st Dec 20147:00 amRNSOxford BioMedica plc Director's Share Purchase
28th Nov 20147:00 amRNSTotal Voting Rights
26th Nov 20147:00 amRNSDirector Dealings
3rd Nov 20147:00 amRNSInterim Management Statement
31st Oct 20147:00 amRNSTotal Voting Rights
17th Oct 20149:27 amRNSDirector's Interest in Share Options
17th Oct 20149:10 amRNSHolding(s) in Company
16th Oct 20144:52 pmRNSDirectorate Change
15th Oct 20145:05 pmRNSHolding(s) in Company
14th Oct 20147:00 amRNSOxford BioMedica plc Director's Share Purchase
13th Oct 20147:00 amRNSOxford BioMedica Acquires Windrush Court Office
10th Oct 20147:41 amRNSAdditional Listing
10th Oct 20147:00 amRNSSecond major agreement with Novartis
28th Aug 20147:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.